0001140361-14-045152.txt : 20141212 0001140361-14-045152.hdr.sgml : 20141212 20141212172918 ACCESSION NUMBER: 0001140361-14-045152 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20141212 DATE AS OF CHANGE: 20141212 EFFECTIVENESS DATE: 20141212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BriaCell Therapeutics Corp. CENTRAL INDEX KEY: 0001610820 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-230050 FILM NUMBER: 141284470 BUSINESS ADDRESS: STREET 1: 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR CITY: WEST VANCOUVER STATE: A1 ZIP: V7T 2X1 BUSINESS PHONE: (604) 921-1810 MAIL ADDRESS: STREET 1: 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR CITY: WEST VANCOUVER STATE: A1 ZIP: V7T 2X1 FORMER COMPANY: FORMER CONFORMED NAME: Ansell Capital Corp. DATE OF NAME CHANGE: 20140613 D 1 primary_doc.xml X0707 D LIVE 0001610820 BriaCell Therapeutics Corp. 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 BRITISH COLUMBIA, CANADA V7T 2X1 (604) 921-1810 BRITISH COLUMBIA, CANADA None Ansell Capital Corp. Corporation true Charles Wiseman 1880 Century Park East, Suite 315 Los Angeles CA CALIFORNIA 90067 Executive Officer Director Saeid Babei 3rd Floor, Bellevue Centre 235 - 15th Street West Vancouver A1 BRITISH COLUMBIA, CANADA V7T 2X1 Director Rahoul A. Sharan 3rd Floor, Bellevue Centre 235 - 15th Street West Vancouver A1 BRITISH COLUMBIA, CANADA V7T 2Z1 Executive Officer Director Isaac Maresky 3rd Floor, Bellevue Centre 235 - 15th Street West Vancouver A1 BRITISH COLUMBIA, CANADA V7T 2X1 Director Biotechnology Not Applicable 06b false 2014-11-27 false true true true true 833,333 Warrants are exercisable to purchase one additional common share at price of $0.25 for first 12 months after closing and $0.35 during the subsequent 24 months. true Acquisition of BriaCell Therapeutics Corp. by Ansell Capital Corp. 0 6006150 6006150 0 Represents value of common shares issued in connection with share exchange, valued at Cdn$0.18 per share; Cdn$1.1333=US$1.00 false 7 0 1 1 PowerOne Capital Markets Limited of Toronto, Ontario, received 200,000 shares as a finder's fee for introducing the Issuer to BriaCell Therapeutics Corp. 0 false BriaCell Therapeutics Corp. /s/ Matthew G. Wright Matthew G. Wright Chief Financial Officer 2014-12-12